Asthmatic women may take longer to become pregnant, according to a new study published in The European Respiratory Journal.
Asthmatic women may take longer to become pregnant, according to a new study published in The European Respiratory Journal.
Researchers from the Bispebjerg University Hospital in Denmark studied 15,250 Danish twins, aged 12 to 41 years, who had participated in a questionnaire study that included questions about asthma and fertility. The women were divided into asthmatic or non-asthmatic groups and the asthmatic group was further divided into treated and non-treated asthmatics. Multiple regression analysis was used to study the difference in time to pregnancy and pregnancy outcomes in asthmatic and non-asthmatic women.
The time to pregnancy for women with asthma was longer than in women without the condition, 27% vs. 21.6%, odds ratio (OR) = 1.31 (1.1 – 1.6), P = 0.009. The association remained significant even after age, age at menarche, body mass index, and socioeconomic status were taken into account (P = 0.05 OR 1.25 [1 – 1.6]). The effect of asthma on fertility was more pronounced in women older than age 30 (32.2% vs. 24.9%, P = 0.04, OR = 1.44 [1.1 – 1.9]).
Women who did not treat their asthma had a significantly elevated risk of prolonged time to pregnancy, compared to healthy women (OR = 1.79 (1.22 – 2.66), P = 0.004). Treated asthma also was associated with delay in achieving pregnancy (OR = 1.40, p = 0.004), but less so than in women in the untreated arm.
The study authors concluded that asthma can cause a delay in becoming pregnant and that it can become more pronounced if the condition is not treated or if a woman is older than age 30. However, they found that asthmatic women tended to begin their families earlier than non-asthmatics, meaning that the average number of children was roughly equal.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More